Clinical and Pharmacologic Considerations for Guanfacine Use in Very Young Children
- 1 August 2016
- journal article
- review article
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 26 (6) , 498-504
Abstract
Objective: Guanfacine, in the immediate release form, remains a commonly used medication for the treatment of clinically significant hyperactivity, impulsivity, or disruptive behaviors. This article reviews the available literature regarding guanfacine use in very young children (Methods: The authors performed electronic literature searches in PubMed through October 2015 using the terms attention-deficit/hyperactivity disorder, guanfacine, and alpha agonists. We also performed an informal review of the literature and used selected articles from relevant reference lists. The result was a broad, qualitative review of the literature, with a focus on specific factors regarding guanfacine use in very young children. Results: Despite the fact that guanfacine is commonly used in very young children, there is a paucity of published studies that looked specifically at its use in this population. In reviewing the pharmacology of guanfacine, there are specific factors that may play a unique role in its disposition in very young children. Conclusions: Guanfacine is an important medication option in very young children; however, there is a significant pharmacologic “information gap,” and further research is needed to help establish appropriate, safe, and effective dosing of guanfacine in this population.Keywords
This publication has 56 references indexed in Scilit:
- Diagnostic and Statistical Manual of Mental Disorders2013
- Psychiatric Disorders in Preschoolers: Continuity From Ages 3 to 6American Journal of Psychiatry, 2012
- ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsPediatrics, 2011
- Parent-reported mental health in preschoolers: findings using a diagnostic interviewComprehensive Psychiatry, 2011
- Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)Journal of Child and Adolescent Psychopharmacology, 2007
- Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New DataJournal of Child and Adolescent Psychopharmacology, 2007
- The Alpha-2A-Adrenoceptor Agonist, Guanfacine, Increases Regional Cerebral Blood Flow in Dorsolateral Prefrontal Cortex of Monkeys Performing a Spatial Working Memory TaskNeuropsychopharmacology, 2000
- Boys' externalizing problems at elementary school age: Pathways from early behavior problems, maternal control, and family stressDevelopment and Psychopathology, 1996
- The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypesThe Journal of Neuroscience, 1988
- α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman PrimatesScience, 1985